NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
![Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… " Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "](https://pbs.twimg.com/media/CiKj8o2W0AAgx8F.jpg)
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
![Big deal: NMD flexes series A muscles - University Venturing: News, Data, and Events - Global University Venturing Big deal: NMD flexes series A muscles - University Venturing: News, Data, and Events - Global University Venturing](https://globaluniversityventuring.com//content/uploads/2018/08/Aarhus_University.jpg)